SNN

Smith & Nephew plc (NYSE:SNN) is a British multinational medical technology company founded in 1856 and headquartered in Watford, United Kingdom. Originally established as a pharmacy business by Thomas James Smith, the company has evolved over more than 165 years into one of the world's leading medical device manufacturers. Smith & Nephew went public on the New York Stock Exchange in 1999 and today operates globally, serving healthcare providers across established and emerging markets. The company has undergone significant strategic transformation in recent years, implementing a comprehensive 12-point improvement plan to enhance operational efficiency and drive consistent growth across its medical device portfolio.